In this studies, BTMP treatment upregulated TKT, decreased D-ribose levels and simultaneously rescued T1DM rats from diabetic-related encephalopathy but did not decrease D-glucose levels. The gene discussed is TKT; the disease is type 1 diabetes mellitus.